Haemonetics Stock In The News
| HAE Stock | USD 65.68 2.62 3.84% |
Our overall analysis of Haemonetics' news coverage and content from conventional and social sources shows investors' bearish mood towards Haemonetics. The specific impact of Haemonetics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Haemonetics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Haemonetics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Haemonetics Backtesting and Haemonetics Hype Analysis. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.
Haemonetics |
Haemonetics Today Top News and Investor Outlook
Haemonetics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Haemonetics and other traded companies coverage with news coverage. We help investors stay connected with Haemonetics headlines for the 13th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Haemonetics Stock performance. Please note that trading solely based on the Haemonetics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Haemonetics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Haemonetics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Haemonetics that are available to investors today. That information is available publicly through Haemonetics media outlets and privately through word of mouth or via Haemonetics internal channels. However, regardless of the origin, that massive amount of Haemonetics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Haemonetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Haemonetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Haemonetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Haemonetics alpha.
Haemonetics Largest EPS Surprises
Earnings surprises can significantly impact Haemonetics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2003-07-24 | 2003-06-30 | 0.1 | 0.11 | 0.01 | 10 | ||
1999-10-28 | 1999-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
1999-01-29 | 1998-12-31 | 0.1 | 0.09 | -0.01 | 10 | ||
2004-07-29 | 2004-06-30 | 0.17 | 0.19 | 0.02 | 11 | ||
2004-05-03 | 2004-03-31 | 0.17 | 0.19 | 0.02 | 11 | ||
2004-01-22 | 2003-12-31 | 0.17 | 0.19 | 0.02 | 11 |
Haemonetics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Haemonetics Stock. The global stock market is bullish. About 65% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
Haemonetics Corp Shares Down 3.63 percent on Mar 12 at gurufocus.com
3rd of March 2025
Haemonetics Names Chan Chief Operating Officer at marketwatch.com
27th of February 2025
Sotera Health Reports Fourth-Quarter and Full-Year 2024 ResultsProvides 2025 Outlook at finance.yahoo.com
25th of February 2025
Haemonetics Corp Stock Price Up 4.6 percent on Feb 25 at gurufocus.com
24th of February 2025
The European Medicines Agency Has Approved an Additional Subcutaneous Administration Optio... at prnewswire.com
21st of February 2025
US Stocks Trading Below Estimated Value In February 2025 at simplywall.st
20th of February 2025
CSL Receives Approval in Japan for ANDEMBRY Subcutaneous Injection 200mg Pens, a Novel Hum... at prnewswire.com
18th of February 2025
Bausch Lomb Reports Earnings Tomorrow What To Expect at finance.yahoo.com
13th of February 2025
Haemonetics Is Posting Promising Earnings But The Good News Doesnt Stop There at simplywall.st
7th of February 2025
HAE Q3 Earnings In Line, 25 Sales View Cut, Stock Up in Aftermarket at zacks.com
3rd of February 2025
Haemonetics Corp Trading Down 3.23 percent on Feb 3 at gurufocus.com
14th of January 2025
Haemonetics Corp Completes Sale of Whole Blood Assets to GVS S.p.A at gurufocus.com
Haemonetics Investors Sentiment
The influence of Haemonetics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Haemonetics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Haemonetics' public news can be used to forecast risks associated with an investment in Haemonetics. The trend in average sentiment can be used to explain how an investor holding Haemonetics can time the market purely based on public headlines and social activities around Haemonetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Haemonetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Haemonetics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Haemonetics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Haemonetics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Haemonetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Haemonetics' short interest history, or implied volatility extrapolated from Haemonetics options trading.
Check out Haemonetics Backtesting and Haemonetics Hype Analysis. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.213 | Earnings Share 2.54 | Revenue Per Share | Quarterly Revenue Growth 0.037 | Return On Assets |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.